<DOC>
	<DOC>NCT00939978</DOC>
	<brief_summary>The administration of rhEPO on the one day before cardiac surgery will be effective to decrease the bleeding due to the surgery.</brief_summary>
	<brief_title>Effect of Preoperative Recombinant Human Erythropoietin on Transfusion Risk in Valvular Heart Surgery</brief_title>
	<detailed_description />
	<mesh_term>Epoetin Alfa</mesh_term>
	<criteria>The 90 patients who are planned to have the heart surgery during this study period.(minimum age 20) Uncontrolled hypertension(diastolic blood pressure(DBP)&gt;100 mmHg), Hct &gt; 45%, Plt. count)&gt;450,000 There are no history of seizure, thrombus, cancer, acute hepatitis, alcoholism, peripheral blood vessel disease, pure red blood cell dysfunction, liver function failure, chronic multiple arthritis. No pregnancy, acute hyper parathyroidism.</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2010</verification_date>
</DOC>